RK

Rajesh Kumar Verma

Active Director Director DIN 09596709
DIN 09596709 First appointment Apr 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Rajesh Kumar Verma

Data last updated:

Rajesh Kumar Verma is a Director at Zedlay Pharma Private Limited (since 2022). The company operates in Trading. Zedlay Pharma Private Limited reported revenue of ₹15.9 Lakh (FY 2023).

DIN 09596709
Primary Designation Director
Industry Trading
First Appointment 30 Apr 2022
Oldest Company Age 5 yrs
Largest company Zedlay Pharma Private Limited · ₹15.9 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zedlay Pharma Private Limited U51909UP2021PTC143674
Director30 Apr 20222021₹15.9 Lakh (FY 2023)Active

Board colleagues of Rajesh Kumar Verma

Directorship timeline

Open interactive timeline →
Zedlay Pharma Private Limited
Premium access

Shareholding and investment profile for Rajesh Kumar Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar Verma

Rajesh Kumar Verma currently holds 1 directorship: Zedlay Pharma Private Limited (Director, since 30 Apr 2022, revenue ₹15.9 Lakh (FY 2023)).

Rajesh Kumar Verma was first appointed on 30 Apr 2022 as Director at Zedlay Pharma Private Limited.

The current boards of Rajesh Kumar Verma's companies include Vishal Kumar Sharma (Zedlay Pharma Private Limited), Yash Sharma (Zedlay Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available